208 results
Page 5 of 11
8-K
EX-99.1
8lffp
14 Mar 13
Ligand Signs Global License Agreement with Spectrum Pharmaceuticals for Captisol-Enabled® Melphalan
12:00am
8-K
EX-99.1
gtu9uisw
4 Dec 12
Regulation FD Disclosure
12:00am
8-K
EX-99.1
y7i68pb298zcvte7
7 Feb 12
Ligand Reports Fourth Quarter and Full Year 2011 Financial Results
12:00am
8-K
EX-99.1
4qia9m
8 Nov 11
Ligand Pharmaceuticals Announces Third Quarter Results
12:00am
8-K/A
EX-99.1
kek45bncnkvi
24 Jun 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
jks4b28yaof8qj
23 Jun 11
Regulation FD Disclosure
12:00am
8-K
wrqsfk
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
nbx3552kdn6
18 Apr 11
Ligand Names Matthew W. Foehr Chief Operating Officer
12:00am
8-K
EX-99.1
tjlg2u3bnq qfa7usic
15 Feb 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
bvgd9xy 90lof9v4v4la
9 Feb 11
Ligand Appoints John L. LaMattina to Board of Directors
12:00am